Oslo, Norway

Tore Skjæret

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Tore Skjæret: Innovator in Fatty Acid Derivatives for Liver Health**

Introduction

Tore Skjæret is a prominent inventor located in Oslo, Norway, recognized for his contributions to the field of medical science, particularly in the treatment of liver conditions. With a notable portfolio comprising six patents, he has made significant strides in developing fatty acid derivatives aimed at combating non-alcoholic steatohepatitis (NASH) and alcoholic steatohepatitis (ASH).

Latest Patents

Tore's latest patents focus on innovative compounds specifically designed for therapeutic use in treating NASH and ASH. One of his key inventions entails a compound that features an unsaturated fatty acid with an oxygen molecule incorporated in the β-position coupled with an α-substituent. This invention not only provides a foundation for potential treatments but also includes methods of administering these compounds, either individually or in combination with other active agents.

Additional patents include specialized methods involving substituted fatty acids that prevent and treat non-alcoholic steatohepatitis. These compounds are outlined with specific chemical formulas that underscore their pharmaceutical efficacy, demonstrating Skjæret's meticulous approach in addressing complex health issues related to liver function.

Career Highlights

Throughout his career, Tore has worked with leading organizations such as Pronova Biopharma Norge AS and BASF AS, gaining invaluable experience in pharmaceutical development. His roles have enabled him to contribute meaningfully to the research and development of therapeutic solutions, particularly in the realm of fatty acid applications.

Collaborations

Tore Skjæret has collaborated with noteworthy professionals in his field, including David Alan Fraser and Ragnar Hovland. These partnerships emphasize a collaborative approach to research and innovation, enhancing the potential impact of his work in combating liver diseases.

Conclusion

In summary, Tore Skjæret stands out as an influential inventor dedicated to advancing treatments for liver health through innovative fatty acid derivatives. His patent portfolio reflects his commitment to research and development in the pharmaceutical industry, positioning him as a significant contributor to medical science in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…